Fitbit, Inc. (FIT)
(Delayed Data from NYSE)
$5.09 USD
+0.13 (2.62%)
Updated May 3, 2019 04:03 PM ET
After-Market: $5.09 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$5.09 USD
+0.13 (2.62%)
Updated May 3, 2019 04:03 PM ET
After-Market: $5.09 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Wearable Spending to Hike Further: 4 Tech Stocks to Consider
by Shilpa Mete
Here we pick four tech stocks with solid fundamentals, which are well-poised to capitalize on growth opportunities in the wearable market.
Apple (AAPL), Biogen to Track Cognitive Health via Wearables
by Zacks Equity Research
Apple (AAPL) is collaborating with Biogen to test whether the Apple Watch and iPhone can collect and transmit biometric data on cognitive performance.
Apple (AAPL) Wallet Can Hold COVID-19 Vaccination Record (Revised)
by Zacks Equity Research
Recipients of COVID-19 vaccines across the Los Angeles County will be offered a digital record, which they can keep in their Apple (AAPL) Wallet app.
Apple (AAPL) Brings COVID-19 Vaccine Tracking With Healthvana
by Zacks Equity Research
Apple (AAPL) partners with Healthvana, a health startup, to bring COVID-19 vaccine tracking in Apple Wallet, which will initially be introduced in Los Angeles County.
4 Exercise-at-Home Stocks to Benefit Amid Surging Coronavirus Infections
by Rajani Lohia
The need to stay fit and healthy amid the pandemic-led lockdowns has led to an increase in exercise-at-home trends. This has resulted in higher demand for fitness accessories, equipment and gears.
The Zacks Analyst Blog Highlights: Apple, Fitbit, Sony and Peloton Interactive
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Apple, Fitbit, Sony and Peloton Interactive
Apple's (AAPL) Health Push Intensifies Competition in Wearables
by Vasundhara Sawalka
The healthcare space is witnessing increasing proliferation of wearables and fitness trackers offered by Apple (AAPL), Fitbit, Garmin and others.
Apple's (AAPL) Airpods Max, Fitness+ to Boost Holiday Sales
by Zacks Equity Research
Apple (AAPL) announces the launch of new over-the-ear, wireless Airpods Max headphones and Apple Fitness+ subscription services to boost holiday sales.
Why Is Fitbit (FIT) Up 2.7% Since Last Earnings Report?
by Zacks Equity Research
Fitbit (FIT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Fitbit Adds New Features to Smartwatches With OS 5.1 Update
by Zacks Equity Research
Fitbit (FIT) adds new voice assistant support feature and other health capabilities to recently released smartwatches.
Lyft (LYFT) Shares Gain Despite Wider-Than-Expected Q3 Loss
by Zacks Equity Research
While LYFT's Q3 results reflect significant impact of coronavirus on a year-over-year basis, it indicates a strong rebound on a sequential basis.
Uber's (UBER) Q3 Loss Wider Than Expected, Shares Decline
by Zacks Equity Research
Weakness in the mobility business due to coronavirus concerns hurt UBER's Q3 results.
Fitbit (FIT) Q3 Loss Narrower Than Estimated, Revenues Beat
by Zacks Equity Research
Fitbit (FIT) reports better-than-expected third-quarter revenues. However, uncertainty around consumer demand continues due to the COVID-19 pandemic.
Fitbit (FIT) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Fitbit (FIT) delivered earnings and revenue surprises of 72.73% and 21.68%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Fitbit (FIT) Q3 Earnings Expected to Decline
by Zacks Equity Research
Fitbit (FIT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Personal Health Peps Up With Garmin: Should Others Take Note?
by Shilpa Mete
Garmin (GRMN) boosts reach in the personal health monitoring space with the rollout of Index S2. This is likely to intensify competition for others.
4 IoT Stocks to Snap Up on Coronavirus-Triggered 5G Boom
by Radhika Pujara
Here we discuss four stocks, including Alphabet (GOOGL), that are well-positioned to make the most of IoT wave amid solid growth in 5G infrastructure spending and proliferation.
Apple Brings Health Records for iPhone to U.K. and Canada
by Zacks Equity Research
Apple (AAPL) recently announced the availability of the Health Records feature within the Health app for users in the United Kingdom and Canada.
Garmin Expands Aviation & Smartwatch Offerings With D2 Air
by Zacks Equity Research
Garmin (GRMN) launches D2 Air watch to expand its D2 aviator watch series.
Company News for Sep 30, 2020
by Zacks Equity Research
Companies In The News Are: SRNE, FIT, GOOGL, NIO, BYND, WMT.
Garmin Strengthens MARQ Family, Bolsters Smartwatch Portfolio
by Zacks Equity Research
Garmin (GRMN) unveils Performance Edition MARQ watches by adding silicon rubber straps and other features to MARQ Athlete, MARQ Adventurer, MARQ Aviator and MARQ Driver.
Wearable Devices Gain Amid Coronavirus: 3 Stocks to Watch
by Trina Mukherjee
Let's keep a watch on these three stocks with respect to wearable devices that have taken substantial steps in the fight against coronavirus.
Garmin Unveils Forerunner 745, Expands Wearable Portfolio
by Zacks Equity Research
Garmin (GRMN) recently unveils a new fitness GPS smartwatch for athletes, the Forerunner 745, which in turn is likely to help it develop a solid product line.
Fitbit's (FIT) ECG App Approval Bolsters Healthcare Efforts
by Zacks Equity Research
Fitbit (FIT) receives clearance for ECG app, which bodes well for its growing heart health management initiatives.
Why Is Fitbit (FIT) Down 2.3% Since Last Earnings Report?
by Zacks Equity Research
Fitbit (FIT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.